研究者詳細 - 森瀬　昌宏

論文 - 森瀬　昌宏

分割表示 93 件中 1 - 20 件目／全件表示 >>

Efficacy and safety of second-line therapy of docetaxel plus ramucirumab after first-line platinum-based chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer (SCORPION): a multicenter, open-label, single-arm, phase 2 trial 招待有り査読有り国際誌

Matsuzawa, R; Morise, M; Ito, K; Hataji, O; Takahashi, K; Koyama, J; Kuwatsuka, Y; Imaizumi, K; Goto, Y; Itani, H; Yamaguchi, T; Zenke, Y; Oki, M; Ishii, M

ECLINICALMEDICINE 66 巻頁： 102303 2023年12月

Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC 査読有り国際共著国際誌

Herbst Roy S., Giaccone Giuseppe, de Marinis Filippo, Reinmuth Niels, Vergnenegre Alain, Barrios Carlos H., Morise Masahiro, Felip Enriqueta, Andric Zoran, Geater Sarayut, Ozguroglu Mustafa, Zou Wei, Sandler Alan, Enquist Ida, Komatsubara Kimberly, Deng Yu, Kuriki Hiroshi, Wen Xiaohui, McCleland Mark, Mocci Simonetta, Jassem Jacek, Spigel David R.

NEW ENGLAND JOURNAL OF MEDICINE 383 巻 ( 14 ) 頁： 1328 - 1339 2020年10月

Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial. 査読有り国際共著国際誌

Wu YL, Guarneri V, Voon PJ, Lim BK, Yang JJ, Wislez M, Huang C, Liam CK, Mazieres J, Tho LM, Hayashi H, Nhung NV, Chia PL, de Marinis F, Raskin J, Zhou Q, Finocchiaro G, Le AT, Wang J, Dooms C, Kato T, Nadal E, Hin HS, Smit EF, Wermke M, Tan D, Morise M, O'Brate A, Adrian S, Pfeiffer BM, Stroh C, Juraeva D, Strotmann R, Goteti K, Berghoff K, Ellers-Lenz B, Karachaliou N, Le X, Kim TM, INSIGHT 2 investigators

The Lancet Oncology 25 巻 ( 8 ) 頁： 989 - 1002 2024年8月

Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE 査読有り国際誌

Hata, A; Okamoto, I; Inui, N; Okada, M; Morise, M; Akiyoshi, K; Takeda, M; Watanabe, Y; Sugawara, S; Shinagawa, N; Kubota, K; Saeki, T; Tamura, T

JOURNAL OF CLINICAL ONCOLOGY 40 巻 ( 2 ) 頁： 180 - + 2022年1月

Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib. 査読有り国際誌

Umemura S, Udagawa H, Ikeda T, Murakami H, Daga H, Toyozawa R, Kozuki T, Sakakibara-Konishi J, Ohe Y, Morise M, Kato T, Shingyoji M, Hara S, Furuya N, Teranishi S, Takata S, Miyamoto S, Nakachi I, Wakabayashi M, Nomura S, Sato A, Ishii G, Tsuchihara K, Sugiyama E, Kirita K, Sakai T, Shibata Y, Izumi H, Nosaki K, Zenke Y, Matsumoto S, Yoh K, Niho S, Goto K

JOURNAL OF THORACIC ONCOLOGY 20 巻 ( 2 ) 頁： 177 - 193 2025年2月

Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC 査読有り国際共著国際誌

Jassem, J; de Marinis, F; Giaccone, G; Vergnenegre, A; Barrios, CH; Morise, M; Felip, E; Oprean, C; Kim, YC; Andric, Z; Mocci, S; Enquist, I; Komatsubara, K; McCleland, M; Kuriki, H; Villalobos, M; Phan, S; Spigel, DR; Herbst, RS

JOURNAL OF THORACIC ONCOLOGY 16 巻 ( 11 ) 頁： 1872 - 1882 2021年11月

Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis 査読有り国際誌

JOURNAL OF THORACIC ONCOLOGY 9 巻 ( 9 ) 頁： 1324 - 1331 2014年9月

Trastuzumab emtansine for patients with non-small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations 査読有り国際誌

Iwama, E; Zenke, Y; Sugawara, S; Daga, H; Morise, M; Yanagitani, N; Sakamoto, T; Murakami, H; Kishimoto, J; Matsumoto, S; Nakanishi, Y; Goto, K; Okamoto, I

EUROPEAN JOURNAL OF CANCER 162 巻頁： 99 - 106 2022年2月

Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION. 査読有り国際共著国際誌

Kato T, Yang JC, Ahn MJ, Sakai H, Morise M, Chen YM, Han JY, Yang JJ, Zhao J, Hsia TC, Berghoff K, Bruns R, Vioix H, Lang S, Johne A, Le X, Paik PK

130 巻 ( 10 ) 頁： 1679 - 1686 2024年6月

A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer 査読有り国際誌

Yasuda, H; Ichihara, E; Sakakibara-Konishi, J; Zenke, Y; Takeuchi, S; Morise, M; Hotta, K; Sato, M; Matsumoto, S; Tanimoto, A; Matsuzawa, R; Kiura, K; Takashima, Y; Yano, S; Koyama, J; Fukushima, T; Hamamoto, J; Terai, H; Ikemura, S; Takemura, R; Goto, K; Soejima, K

162 巻頁： 140 - 146 2021年12月

Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan 査読有り国際誌

Hasegawa, S; Shintani, Y; Takuwa, T; Aoe, K; Kato, K; Fujimoto, N; Hida, Y; Morise, M; Moriya, Y; Morohoshi, T; Suzuki, H; Chida, M; Endo, S; Kadokura, M; Okumura, M; Hattori, S; Date, H; Yoshino, I

CANCER SCIENCE 115 巻 ( 2 ) 頁： 507 - 528 2024年2月

Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study 査読有り国際共著国際誌

Morise, M; Kato, T; Matsumoto, S; Inoue, T; Sakamoto, T; Tokito, T; Atagi, S; Kozuki, T; Takeoka, H; Chikamori, K; Shinagawa, N; Tanaka, H; Horii, E; Adrian, S; Bruns, R; Johne, A; Paik, PK; Sakai, H

CANCER SCIENCE 115 巻 ( 4 ) 頁： 1296 - 1305 2024年4月

Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer. 査読有り国際誌

Koyama J, Morise M, Furukawa T, Oyama S, Matsuzawa R, Tanaka I, Wakahara K, Yokota H, Kimura T, Shiratori Y, Kondoh Y, Hashimoto N, Ishii M

BMC cancer 24 巻 ( 1 ) 頁： 1417 2024年11月

Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR 査読有り国際誌

Matsuzawa, R; Morise, M; Kinoshita, F; Tanaka, I; Koyama, J; Kimura, T; Kondoh, Y; Tanaka, T; Shima, K; Hase, T; Wakahara, K; Ishii, M; Hashimoto, N

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 149 巻 ( 7 ) 頁： 3885 - 3893 2023年7月

A multicenter cohort study of osimertinib compared with afatinib as first-line treatment for EGFR-mutated non-small-cell lung cancer from practical dataset: CJLSG1903 査読有り国際誌

Ito, K; Morise, M; Wakuda, K; Hataji, O; Shimokawaji, T; Takahashi, K; Furuya, N; Takeyama, Y; Goto, Y; Abe, T; Kato, T; Ozone, S; Ikeda, S; Kogure, Y; Yokoyama, T; Kimura, M; Yoshioka, H; Murotani, K; Kondo, M; Saka, H

ESMO OPEN 6 巻 ( 3 ) 頁： 100115 2021年6月

Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung 査読有り国際誌

Morise M, Hishida T, Takahashi A, Yoshida J, Ohe Y, Nagai K, Ishii G

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 141 巻 ( 12 ) 頁： 2121 - 2130 2015年12月

Nongenomic Effects of Fluticasone Propionate and Budesonide on Human Airway Anion Secretion 査読有り国際誌

Mizutani, T; Morise, M; Ito, Y; Hibino, Y; Matsuno, T; Ito, S; Hashimoto, N; Sato, M; Kondo, M; Imaizumi, K; Hasegawa, Y

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 47 巻 ( 5 ) 頁： 645 - 651 2012年11月

Capsaicinoids Regulate Airway Anion Transporters through Rho Kinase- and Cyclic AMP-Dependent Mechanisms 査読有り国際誌

Hibino, Y; Morise, M; Ito, Y; Mizutani, T; Matsuno, T; Ito, S; Hashimoto, N; Sato, M; Kondo, M; Imaizumi, K; Hasegawa, Y

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 45 巻 ( 4 ) 頁： 684 - 691 2011年10月

Heterologous regulation of anion transporters by menthol in human airway epithelial cells 査読有り国際誌

Morise, M; Ito, Y; Matsuno, T; Hibino, Y; Mizutani, T; Ito, S; Hashimoto, N; Kondo, M; Imaizumi, K; Hasegawa, Y

EUROPEAN JOURNAL OF PHARMACOLOGY 635 巻 ( 1-3 ) 頁： 204 - 211 2010年6月

Phase II study of erlotinib for previously treated patients with EGFR wild-type non-small-cell lung cancer, following EGFR mutation status reevaluation with the Scorpion Amplified Refractory Mutation System. 査読有り国際誌

Morise M, Taniguchi H, Saka H, Shindoh J, Suzuki R, Kojima E, Hase T, Ando M, Kondo M, Saito H, Hasegawa Y

MOLECULAR AND CLINICAL ONCOLOGY 2 巻 ( 6 ) 頁： 991 - 996 2014年11月

　前のページ - 次のページ　

<森瀬 昌宏>

論文 - 森瀬 昌宏

<森瀬　昌宏>

論文 - 森瀬　昌宏